{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-013294","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2024-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.351763+00:00","generated_at":"2026-06-06T03:21:36.197887+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NeuroOne Q1 revenue jumps to $978k; OneRF Ablation System receives FDA clearance","bullets":["Product revenue $978k in Q1 fiscal 2024, up from $115k in Q1 2023.","Net loss $3.3M vs $1.7M YoY; cash $2.7M at Dec 31, 2023.","FDA 510(k) clearance for OneRF Ablation System in Dec 2023; limited commercial launch expected Q2 2024.","Zimmer Biomet sales force trained for Evo sEEG; new accounts expected to drive revenue growth.","Raised $2.8M via ATM offering at avg $1.45/share in Dec 2023 – Jan 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-013294","json":"https://secwatch.observer/filing/0001213900-24-013294.json","markdown":"https://secwatch.observer/filing/0001213900-24-013294.md","text":"https://secwatch.observer/filing/0001213900-24-013294.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024013294/0001213900-24-013294-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024013294/ea193484-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T03:21:36.197887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c7be96e0a8078d9fd23b204b049251ed10a9a94e","claim":"NEUROONE MEDICAL TECHNOLOGIES Corp reported financial results for first quarter fiscal year 2024 ended December 31, 2023.","evidence_excerpt":"On February 13, 2024, NeuroOne Medical Technologies Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024013294/0001213900-24-013294-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter fiscal year 2024 ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}